Guangdong Vtr Bio-Tech Co.Ltd(300381)
Independent directors on the 7th board of directors of the company
Independent opinions approved in advance on relevant matters of the 17th meeting
As an independent director of Guangdong Vtr Bio-Tech Co.Ltd(300381) (hereinafter referred to as “the company”), based on independent judgment, in accordance with the company law, the securities law, the guiding opinions on the establishment of independent director system in listed companies, the guidelines for the standardized operation of companies listed on the gem of Shenzhen stock exchange and other laws and regulations, normative documents and the relevant provisions of the articles of association, The company has conducted a pre examination on the relevant proposals to be considered at the 17th meeting of the seventh board of directors. After reviewing the relevant materials, we have issued the following pre approval opinions: the pre approval opinions on the renewal of the audit institution in 2022
We believe that Grant Thornton Certified Public Accountants (special general partnership) adheres to the principle of independent audit in the process of practice, can issue various professional reports for the company on time, and the contents of the report are objective and fair. We agree that the company will continue to hire Grant Thornton Certified Public Accountants (special general partnership) as the audit institution of the company in 2022. We agree to submit the proposal to the board of directors of the company for deliberation.
(no text below)
(there is no text on this page, which is the signature page of independent directors’ independent opinions on matters related to the 17th meeting of the seventh board of directors)
Wang Yifei, Li Anxing, Zhu Zuyin
April 23, 2022
